Target intelligence / Profile preview

Multiciliate differentiation and DNA synthesis associated protein (MCIDAS) (MCIDAS)

Target
MCIDAS
Molecular classification
Transcription regulator, Transcription co-activator
01

Overview

Multiciliate differentiation and DNA synthesis associated protein (MCIDAS), also known as Multicilin, is a specialized transcriptional co-activator essential for the production of multiciliated cells (UniProt Q6A162). It functions by forming a ternary complex with E2F transcription factors (E2F4 or E2F5) and DP1, which then binds to and activates the promoters of genes required for centriole biogenesis and motile cilia assembly, such as CCNO and CDC20B (Ma et al., 2014). This protein is critical for the development of tissues that rely on ciliary motion, including the respiratory epithelium, the lining of the brain ventricles, and the fallopian tubes. Mutations in the MCIDAS gene are a primary cause of Reduced Generation of Multiple Motile Cilia (RGMC), a rare ciliopathy characterized by chronic respiratory infections, bronchiectasis, and infertility (Boon et al., 2014). Although there are currently no approved small-molecule drugs targeting MCIDAS, it is a major focus for genetic screening and potential gene therapy aimed at restoring ciliary function in affected patients. Its dual role in regulating both multiciliogenesis and aspects of the cell cycle suggests that its precise regulation is vital to prevent aberrant cell proliferation or developmental defects (Stubbs et al., 2012).

Other names
MulticilinIDASProtein MCIDASMCIMCIN
02

Mechanism of action

MCIDAS acts as a transcriptional co-activator by forming a complex with E2F4/5 and DP1 to trigger the expression of genes required for centriole assembly and multiciliogenesis (Ma et al., 2014).

03

Biological functions

MulticiliogenesisCentriole amplificationCell cycle regulationDNA synthesisCiliary assembly
04

Disease associations

Reduced generation of multiple motile cilia (RGMC)Primary ciliary dyskinesiaChronic respiratory infectionsInfertilityHydrocephalus
05

Safety considerations

Potential for oncogenic transformation if overexpressedDisruption of normal cell cycle progression
06

Biomarkers

MCIDAS mutation statusCiliary beat frequencyPresence of multiple basal bodies in airway epithelium

Beyond the preview

Go deeper on Multiciliate differentiation and DNA synthesis associated protein (MCIDAS) (MCIDAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiciliate differentiation and DNA synthesis associated protein (MCIDAS) (MCIDAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call